Italian translation and validation of the CGM satisfaction scale questionnaire.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
May 2023
Historique:
received: 03 01 2023
accepted: 27 01 2023
medline: 3 4 2023
pubmed: 23 2 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Patient-reported outcomes (PROs) are increasingly important for assessing patient satisfaction with diabetes technologies. PROs must be assessed with validated questionnaires in clinical practice and research studies. Our aim was to translate and validate the Italian version of the continuous glucose monitoring (CGM) Satisfaction (CGM-SAT) scale questionnaire. Questionnaire validation followed MAPI Research Trust guidelines and included forward translation, reconciliation, backward translation, and cognitive debriefing. The final version of the questionnaire was administered to 210 patients with type 1 diabetes (T1D) and 232 parents. The completion rate was excellent, with almost 100% of items answered. The overall Cronbach's coefficient was 0.71 and 0.85 for young people (patients) and parents indicating moderate and good internal consistency, respectively. Parent-young people agreement was 0.404 (95% confidence interval: 0.391-0.417), indicating moderate agreement between the two assessments. Factor analysis identified that factors assessing the "benefits" and "hassles" of CGM accounted for 33.9% and 12.9% of score variance in young people and 29.6% and 19.8% in parents, respectively. We present the successful Italian translation and validation of the CGM-SAT scale questionnaire, which will be useful for assessing satisfaction with Italian T1D patients using CGM systems.

Identifiants

pubmed: 36808474
doi: 10.1007/s00592-023-02043-w
pii: 10.1007/s00592-023-02043-w
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

673-679

Informations de copyright

© 2023. Springer-Verlag Italia S.r.l., part of Springer Nature.

Références

@@@ Sacristan JA (2013) Patient-centered medicine and patient-oriented research: improving health outcomes for individual patients. BMC Med Inform Decis Mak 13:6. https://doi.org/10.1186/1472-6947-13-16
doi: 10.1186/1472-6947-13-16 pubmed: 23294526 pmcid: 3575265
@@@ Saisho Y (2018) Use of diabetes treatment satisfaction questionnaire in diabetes care: importance of patient-reported outcomes. Int J Environ Res Public Health 15(5):947. https://doi.org/10.3390/ijerph15050947
doi: 10.3390/ijerph15050947 pubmed: 29747423 pmcid: 5981986
@@@Pettus JH, Kushner JA, Valentine V et al (2019) Adjunct therapy in type 1 diabetes: a survey to uncover unmet needs and patient preferences beyond HbA1c measures. Diabetes Technol Ther 21(6):336–343. https://doi.org/10.1089/dia.2019.0027
doi: 10.1089/dia.2019.0027 pubmed: 31095422 pmcid: 6551969
@@@ https://www.eunethta.eu/wp-content/uploads/2018/07/OTJA08_CGM-real-time-and-FGM-aspersonal2c-standalone-systems-in-patients-with-diabetes-mellitus-treatedwith-insulin.pdf
@@@Franceschi R, Micheli F, Mozzillo E et al (2021) Intermittently scanned and continuous glucose monitor systems: a systematic review on psychological outcomes in pediatric patients. Front Pediatr 9:6601763. https://doi.org/10.3389/fped.2021.660173
doi: 10.3389/fped.2021.660173
@@@Diabetes Research in Children Network (DirecNet) Study G (2005) Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 28(8):1929–1935
@@@Tansey M, Laffel L, Cheng J et al (2011) Satisfaction with continuous glucose monitoring in adults and youths with type 1 diabetes. Diabet Med 28:1118–1122. https://doi.org/10.1111/j.1464-5491.2011.03368.x
@@@Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring. Diabetes Technol Ther 12(9):679–684. https://doi.org/10.1089/dia.2010.0015
@@@Farfel A, Liberman A, Yackobovitch-Gavan M, Phillip M, Nimri R (2020) Executive functions and adherence to continuous glucose monitoring in children and adolescents with type 1 diabetes. Diabetes Technol Ther 22(4):265–270. https://doi.org/10.1089/dia.2019.0341
doi: 10.1089/dia.2019.0341 pubmed: 31789577
@@@Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Beck RW, Lawrence JM et al (2010) Quality-of-life measures in children and adults with type 1 diabetes: Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomized trial. Diabetes Care 33(10):2175–2177. https://doi.org/10.2337/dc10-0331
@@@Beck RW, Riddlesworth T, Ruedy K et al (2017) Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA 317:371–378. https://doi.org/10.1001/jama.2016.19975
@@@Ruedy KJ, Parkin CG, Riddlesworth TD, Graham C, DIAMOND Study Group (2017) Continuous glucose monitoring in older adults with type 1 and type 2 diabetes using multiple daily injections of insulin: results from the DIAMOND trial. J Diabetes Sci Technol 11(6):1138–1146. https://doi.org/10.1177/1932296817704445
@@@Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126(5):1763–1768. https://doi.org/10.1213/ANE.0000000000002864
doi: 10.1213/ANE.0000000000002864 pubmed: 29481436
@@@Tsalikian E, Fox L, Weinzimer S et al (2012) Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes. Pediatr Diabetes 13(4):301–307. https://doi.org/10.1111/j.1399-5448.2011.00837.x
@@@Diabetes Research in Children Network (DirecNet) Study Group (2006) Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 7(1):32–38. https://doi.org/10.1111/j.1399-543X.2006.00142.x
@@@Rasbach LE, Volkening LK, Markowitz JT, Butler DA, Katz ML, Laffel LM (2015) Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties. Diabetes Technol Ther 17(5):327–334. https://doi.org/10.1089/dia.2014.0366
doi: 10.1089/dia.2014.0366 pubmed: 25695341 pmcid: 4397990

Auteurs

Enza Mozzillo (E)

Department of Translational Medical Science, Section of Pediatrics, Università Degli Studi Di Napoli Federico II, Naples, Italy.

Marco Marigliano (M)

Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Alda Troncone (A)

Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania "L. Vanvitelli", Naples, Italy.

Claudio Maffeis (C)

Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Elisa Morotti (E)

Department of Surgery, Dentistry, Pediatrics and Gynecology, Section of Pediatric Diabetes and Metabolism, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.

Francesca Di Candia (F)

Department of Translational Medical Science, Section of Pediatrics, Università Degli Studi Di Napoli Federico II, Naples, Italy.

Ludovica Fedi (L)

Department of Translational Medical Science, Section of Pediatrics, Università Degli Studi Di Napoli Federico II, Naples, Italy.

Dario Iafusco (D)

Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania "L. Vanvitelli", Naples, Italy.

Angela Zanfardino (A)

Department of Woman, Child and General and Specialistic Surgery, Regional Center of Pediatric Diabetes, University of Campania "L. Vanvitelli", Naples, Italy.

Vittoria Cauvin (V)

Department of Pediatrics, S.Chiara Hospital of Trento, APSS, Trento, Trentino-Alto Adige, Italy.

Riccardo Pertile (R)

Clinical and Evaluative Epidemiology Unit, Department of Governance, APSS, Trento, Italy.

Giulio Maltoni (G)

Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Stefano Zucchini (S)

Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.

Valentino Cherubini (V)

Department of Women's and Children's Health, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Di Ancona, "G. Salesi Hospital", Ancona, Italy.

Valentina Tiberi (V)

Department of Women's and Children's Health, Azienda Ospedaliero-Universitaria, Ospedali Riuniti Di Ancona, "G. Salesi Hospital", Ancona, Italy.

Nicola Minuto (N)

Pediatric Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Marta Bassi (M)

Pediatric Clinic, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Ivana Rabbone (I)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.

Silvia Savastio (S)

Division of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.

Davide Tinti (D)

Center of Pediatric Diabetology- A.O.U. Città della Salute e della Scienza di Turin, Turin, Italy.

Gianluca Tornese (G)

Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy.

Riccardo Schiaffini (R)

Pediatric Diabetology Department, Bambino Gesu Pediatric Hospital Roma, Lazio, Italy.

Stefano Passanisi (S)

Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy.

Fortunato Lombardo (F)

Department of Human Pathology of Adulthood and Childhood G. Barresi, University of Messina, Messina, Italy.

Riccardo Bonfanti (R)

Department of Pediatrics, Diabetes Research Institute, IRCCS San Raffaele, Milan, Italy.

Andrea Scaramuzza (A)

Pediatric Diabetes, Endocrinology and Nutrition, Pediatric Unit, ASST Cremona, Ospedale Maggiore, Viale Concordia 1, 26100, Cremona, Italy. andrea.scaramuzza@asst-cremona.it.

Roberto Franceschi (R)

Department of Pediatrics, S.Chiara Hospital of Trento, APSS, Trento, Trentino-Alto Adige, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH